Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers HONG KONG, Jan. 22, 2025 /PRNewswire/ — Today, Lepu Biopharma Co., Ltd (Stock… CISION PRNewswireJanuary 22, 2025
Form Technologies Acquired by Ares Management ~$304 Million of New Equity Capital to Support Deleveraging and Accelerate Company’s… CISION PRNewswireJanuary 22, 2025
Press ReleaseAgoda Announces Hong Kong's Lunar New Year Travel Trends HONG KONG, Jan. 22, 2025 /PRNewswire/ — Digital travel platform Agoda announces… CISION PRNewswireJanuary 22, 2025
Breaking Down Silos: IQAX eBL Interoperability Approved by IG P&I Clubs HONG KONG, Jan. 22, 2025 /PRNewswire/ — IQAX Limited’s electronic bill of… CISION PRNewswireJanuary 22, 2025
Databricks Expands Presence in ASEAN Amid a 70+% Annualized Growth, Announces Plans to Enter Indonesia Availability of Databricks infrastructure in the Amazon Web Services’ (AWS) Asia Pacific (Jakarta)… CISION PRNewswireJanuary 22, 2025
Antennova Presents Latest Phase I/II Data on ATN-022 in Advanced/Metastatic Gastric Cancer, Including an ORR of 42.9%, at ASCO GI 2025 BOSTON, Jan. 22, 2025 /PRNewswire/ — Antennova, a clinical-stage biotech company focused… CISION PRNewswireJanuary 22, 2025
Press ReleaseThailand to Showcase Medical and Wellness Excellence at Expo 2025 Osaka, Kansai, Japan BANGKOK, Jan. 22, 2025 /PRNewswire/ — Thailand is set to make a… CISION PRNewswireJanuary 22, 2025
Press ReleaseCKGSB Professor Wang Neng Receives 2024 CBER-Circle Insight Award for Groundbreaking Research in Blockchain Economics BEIJING, Jan. 22, 2025 /PRNewswire/ — Professor WANG Neng, Dean’s Distinguished Chair Professor… CISION PRNewswireJanuary 22, 2025
